Choosing a study population for the evaluation of antifungal prophylaxis.
Cornely
Oliver A
OA
Ullmann
Andrew J
AJ
Karthaus
Meinolf
M
D000935:Antifungal Agents / Q000627:therapeutic use*; D054714:Echinocandins; D015725:Fluconazole / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D055666:Lipopeptides; D008074:Lipoproteins / Q000627:therapeutic use; D000077551:Micafungin; D009181:Mycoses / Q000209:etiology / Q000517:prevention & control*; D018579:Patient Selection; D010456:Peptides, Cyclic / Q000627:therapeutic use
D000935:Antifungal Agents; D054714:Echinocandins; D055666:Lipopeptides; D008074:Lipoproteins; D010456:Peptides, Cyclic; D015725:Fluconazole; D000077551:Micafungin